Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -
Please visit our MS learning channel on YouTube, which provides hundreds of MS videos presented by MS Experts across the USA, from many of our recorded education programs. Archived here: www.youtube.com/msviewsandnews -- Additionally, please visit our Social media platforms: Facebook, Twitter, and Instagram
Important Resources for the MS community are found on the left side of this blog.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Tuesday, September 13, 2016
Early intervention benefits patients with multiple sclerosis
Click here to receive MS news via e-mail
Early treatment has long-lasting effects on MS activity, researchers found in a study published in the Aug. issue of Neurology, a medical journal from the American Academy of Neurology. According to a Newswise press release, researchers studied 468 patients randomly assigned to receive either early treatment or placebo.
After participants were diagnosed with MS or after two years, the participants could switch from placebo to an interferon beta-1b drug or something similar, the press released stated. After 11 years, researchers reevaluated the 278 who remained in the study. Those who had early treatment were 33% less likely to be diagnosed with MS than those who received delayed treatment, according to the study.
“Overall, early treatment appears to have a benefit on relapses, especially early in the disease, but limited effects on other outcome measures, including outcomes reported by patients,” said Brian C. Healy, PhD, in the press release. Healy is on staff at Brigham and Women’s Hospital and Massachusetts General Hospital in Boston and a member of the American Academy of Neurology, who wrote an accompanying editorial.
MS Views and News
Providing educational information, resources and services for those affected by MS